Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock par value $0.001 per share
-
Shares outstanding
-
134M
-
Number of holders
-
85
-
Total 13F shares, excl. options
-
36.3M
-
Shares change
-
+8.65M
-
Total reported value, excl. options
-
$146M
-
Value change
-
+$42.6M
-
Put/Call ratio
-
1.09
-
Number of buys
-
46
-
Number of sells
-
-35
-
Price
-
$4.02
Significant Holders of Ovid Therapeutics Inc. - Common Stock par value $0.001 per share (OVID) as of Q1 2021
104 filings reported holding OVID - Ovid Therapeutics Inc. - Common Stock par value $0.001 per share as of Q1 2021.
Ovid Therapeutics Inc. - Common Stock par value $0.001 per share (OVID) has 85 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 36.3M shares
of 134M outstanding shares and own 27.07% of the company stock.
Largest 10 shareholders include BVF INC/IL (6.42M shares), EcoR1 Capital, LLC (6.08M shares), BlackRock Inc. (3.7M shares), VANGUARD GROUP INC (3.5M shares), Artal Group S.A. (2.5M shares), Stonepine Capital Management, LLC (2.48M shares), STATE STREET CORP (1.2M shares), Ikarian Capital, LLC (1.12M shares), ACADIAN ASSET MANAGEMENT LLC (962K shares), and GEODE CAPITAL MANAGEMENT, LLC (764K shares).
This table shows the top 85 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.